cGMP Distribution Services: Uninterrupted Supply To Meet Demand

An increase in campaign volumes can significantly disrupt a biopharmaceutical company's operational costs and materials supply chain. Thermo Fisher Scientific was called in by a large biopharmaceutical company to address this issue and their concerns about the potential increase in risk for production delays. Additionally, the company was concerned about the site’s warehouse capacity for direct raw materials. After analyzing the current state process flow from raw material sourcing to the manufacturing suites and reviewing the chemical bill of material, Thermo Fisher Scientific was able to present a solution. They proposed that the customer aggregate their sourcing of production chemicals leveraging the Production Chemicals and Sourcing Services, and cGMP Distribution Services offered by the company.